journal article·2018-08-18Open access

Zinc oxide/silver bimetallic nanoencapsulated in PVP/PCL nanofibres for improved antibacterial activity

Min Hu, Chenwen Li, Xin Li, Min Zhou, Jianbin Sun, Fangfang Sheng, Sanjun Shi, Laichun Lu

Abstract

The anti-infection ability and skin regeneration are important aspects on the progress of wound healing, which needs an ideal wound dressing that not only resists bacteria but also promotes skin regeneration. In this study, zinc oxide/silver/polyvinylpyrrolidone/polycaprolactone (ZnO/Ag/PVP/PCL) nanofibres were prepared through electrospinning. Firstly, zinc oxide nanoparticles (ZnONPs) and silver nanoparticle (AgNPs) were synthesized respectively. Secondly, the two nanoparticles were mixed with polyvinylpyrrolidone (PVP) and polycaprolactone (PCL) to obtain the nanofibres. The results of scanning electron microscopy (SEM) showed that ZnONPs and AgNPs were 40.07 ± 9.70 nm and 37.46 ± 12.02 nm, respectively. After electrospinning, the nanofibres were 368.22 ± 123.96 nm in diameter. Infrared spectroscopy revealed that ZnONPs/AgNPs bimetallic nanomaterials were physically embedded in the nanofibres. The antibacterial effects against Staphylococcus aureus and Escherichia coli of ZnO/Ag/PVP/PCL nanofibres were significantly better than these of the single metal material-loaded nanofibres. More importantly, the combination of ZnO and Ag reduced the cytotoxicity of ZnO/Ag/PVP/PCL bimetallic nanofibres toward fibroblasts. These findings demonstrated that ZnO/Ag/PVP/PCL bimetallic nanofibres should be of greater interest than the single metal nanomaterial-loaded nanofibres in inhibiting growth of bacteria.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Teaching Experimental Center, College of Pharmacy, Third Military Medical University, Chongqing, China;

Department of Pharmacy, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

References (28)

Show source-provided references
1. 10.1016/j.addr.2013.07.01110.1016/j.addr.2013.07.011 ↗
2. 10.1016/j.ijbiomac.2016.12.00910.1016/j.ijbiomac.2016.12.009 ↗
3. 10.1016/j.carbpol.2016.09.05110.1016/j.carbpol.2016.09.051 ↗
4. 10.1021/acs.biomac.5b0044710.1021/acs.biomac.5b00447 ↗
5. 10.1016/j.msec.2016.12.09710.1016/j.msec.2016.12.097 ↗
6. 10.1016/j.ijpharm.2013.11.03510.1016/j.ijpharm.2013.11.035 ↗
7. 10.1016/j.clinbiochem.2017.01.01010.1016/j.clinbiochem.2017.01.010 ↗
8. Umair M · PLoS One · 2016 · 11 · e015470410.1371/journal.pone.0162016 ↗
9. Rădulescu M · Rom J Morphol Embryol · 2016 · 57 · 107
10. 10.3390/ijms1709153410.3390/ijms17091534 ↗
11. 10.1016/j.jinorgbio.2013.10.00410.1016/j.jinorgbio.2013.10.004 ↗
12. 10.3109/21691401.2016.116371510.3109/21691401.2016.1163715 ↗
13. 10.1080/21691401.2017.134592110.1080/21691401.2017.1345921 ↗
14. 10.1093/mutage/gew06010.1093/mutage/gew060 ↗
15. 10.3349/ymj.2014.55.2.28310.3349/ymj.2014.55.2.283 ↗
16. 10.1111/j.1365-4632.2010.04815.x10.1111/j.1365-4632.2010.04815.x ↗
17. 10.1016/j.carbpol.2012.02.05810.1016/j.carbpol.2012.02.058 ↗
18. Jafari A · Afr J Microbiol Res · 2011 · 5 · 5465
19. 10.1016/j.actbio.2009.09.01810.1016/j.actbio.2009.09.018 ↗
20. 10.1016/j.ijbiomac.2016.07.05010.1016/j.ijbiomac.2016.07.050 ↗
21. Li C · Int J Nanomed · 2013 · 8 · 4131
22. 10.1007/s10856-009-3877-z10.1007/s10856-009-3877-z ↗
23. 10.1016/j.enzmictec.2016.08.00910.1016/j.enzmictec.2016.08.009 ↗
24. 10.1016/j.envpol.2014.09.00210.1016/j.envpol.2014.09.002 ↗
25. 10.1088/0957-4484/18/22/22510310.1088/0957-4484/18/22/225103 ↗
26. 10.1186/1743-8977-11-1510.1186/1743-8977-11-15 ↗
27. 10.1089/wound.2013.050610.1089/wound.2013.0506 ↗
28. 10.1007/s12010-013-0461-210.1007/s12010-013-0461-2 ↗